Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Overview of Metabolism01:40

Overview of Metabolism

Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual asparagine-depriving nanoparticles against solid tumors.

Nature communications·2025
Same author

Unzippable Siamese Nanoparticles for Programmed Two-Stage Cancer Immunotherapy.

Advanced materials (Deerfield Beach, Fla.)·2024
Same author

Dismantlable Coronated Nanoparticles for Coupling the Induction and Perception of Immunogenic Cell Death.

Advanced materials (Deerfield Beach, Fla.)·2024
Same author

Reshaping Intratumoral Mononuclear Phagocytes with Antibody-Opsonized Immunometabolic Nanoparticles.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2023
Same author

Targeted Reprogramming of Vitamin B<sub>3</sub> Metabolism as a Nanotherapeutic Strategy towards Chemoresistant Cancers.

Advanced materials (Deerfield Beach, Fla.)·2023
Same author

Slimming and Reinvigorating Tumor-Associated Dendritic Cells with Hierarchical Lipid Rewiring Nanoparticles.

Advanced materials (Deerfield Beach, Fla.)·2023

Related Experiment Video

Updated: Jul 10, 2026

Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
15:33

Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation

Published on: October 29, 2013

28.8K

Multiplex Methionine Modulating Hydrogel for Cancer Metabolic Therapy.

Siyu Ma1, Wen Zhu1, Xiaoyuan Ji1

  • 1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Advanced Materials (Deerfield Beach, Fla.)
|May 16, 2025
PubMed
Summary

This study developed a novel hydrogel therapy to block methionine metabolism in tumor cells, effectively inhibiting cancer growth and enhancing immune responses. This localized approach offers a promising new strategy for amino acid starvation-based cancer treatments.

Keywords:
S‐adenosyl methioninecancer metabolic therapyhydrogelnanoparticletriple methionine modulation

More Related Videos

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.5K
Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study
10:44

Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study

Published on: September 22, 2023

1.3K

Related Experiment Videos

Last Updated: Jul 10, 2026

Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation
15:33

Microwave-assisted Functionalization of Polyethylene glycol and On-resin Peptides for Use in Chain Polymerizations and Hydrogel Formation

Published on: October 29, 2013

28.8K
Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

2.5K
Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study
10:44

Author Spotlight: In Vitro Hydrogel Model for Glioblastoma Microenvironment Study

Published on: September 22, 2023

1.3K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Cancer Therapeutics

Background:

  • Tumor cells exhibit high dependence on methionine, making it a potential therapeutic target.
  • Systemic methionine restriction can cause side effects due to methionine's essential metabolic roles.

Purpose of the Study:

  • To develop a localized drug delivery system for multilayered methionine blockade within tumors.
  • To investigate the therapeutic efficacy of a novel hydrogel in preclinical cancer models.

Main Methods:

  • Encapsulation of small molecule inhibitors (PF9366, adenosine dialdehyde) and JPH203 into tumor-targeting nanoparticles (NPs).
  • Co-loading of NPs into a reactive oxygen species-sensitive hydrogel to form the multiplex methionine modulating hydrogel (3 M Gel).
  • Evaluation of 3 M Gel efficacy in murine models of triple-negative breast cancer, hepatocellular carcinoma, and colorectal cancer.

Main Results:

  • 3 M Gel effectively restricted S-adenosyl methionine generation and histone methylation in tumors.
  • The treatment stimulated immunogenic cell death and potent immune responses, restraining tumor progression.
  • 3 M Gel remodeled the tumor microenvironment, overcoming immune checkpoint blockade resistance in triple-negative breast cancer.

Conclusions:

  • The developed 3 M Gel provides a localized triple regulation strategy for methionine metabolism.
  • This approach offers a novel pathway for amino acid starvation-based cancer therapy with enhanced efficacy and reduced systemic side effects.